Avicanna Stock Performance
| AVCN Stock | CAD 0.25 0.01 3.85% |
Avicanna has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Avicanna are expected to decrease at a much lower rate. During the bear market, Avicanna is likely to outperform the market. Avicanna right now shows a risk of 4.54%. Please confirm Avicanna standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Avicanna will be following its price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Avicanna are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Avicanna may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
| Begin Period Cash Flow | 477.2 K |
Avicanna |
Avicanna Relative Risk vs. Return Landscape
If you would invest 25.00 in Avicanna on April 20, 2025 and sell it today you would earn a total of 0.00 from holding Avicanna or generate 0.0% return on investment over 90 days. Avicanna is generating 0.1002% of daily returns and assumes 4.5351% volatility on return distribution over the 90 days horizon. Simply put, 40% of stocks are less volatile than Avicanna, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Avicanna Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avicanna's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Avicanna, and traders can use it to determine the average amount a Avicanna's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0221
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | AVCN | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.54 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.1 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Avicanna is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avicanna by adding it to a well-diversified portfolio.
Avicanna Fundamentals Growth
Avicanna Stock prices reflect investors' perceptions of the future prospects and financial health of Avicanna, and Avicanna fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Avicanna Stock performance.
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.1) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 29.21 M | ||||
| Shares Outstanding | 113.81 M | ||||
| Price To Book | 9.79 X | ||||
| Price To Sales | 1.17 X | ||||
| Revenue | 25.46 M | ||||
| EBITDA | (3.19 M) | ||||
| Cash And Equivalents | 12.98 M | ||||
| Cash Per Share | 0.66 X | ||||
| Total Debt | 10.38 M | ||||
| Debt To Equity | 6.30 % | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | (2.55 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Total Asset | 20.12 M | ||||
| Retained Earnings | (102.09 M) | ||||
About Avicanna Performance
By examining Avicanna's fundamental ratios, stakeholders can obtain critical insights into Avicanna's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Avicanna is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Avicanna Inc. focuses on the research and development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts in North America, Latin America, Europe, and Asia. The company was founded in 2016 and is headquartered in Toronto, Canada. AVICANNA INC operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 77 people.Things to note about Avicanna performance evaluation
Checking the ongoing alerts about Avicanna for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Avicanna help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Avicanna has some characteristics of a very speculative penny stock | |
| Avicanna had very high historical volatility over the last 90 days | |
| Avicanna has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 25.46 M. Net Loss for the year was (3.62 M) with profit before overhead, payroll, taxes, and interest of 13.51 M. | |
| Avicanna has accumulated about 12.98 M in cash with (2.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.66, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 27.0% of the company shares are held by company insiders |
- Analyzing Avicanna's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Avicanna's stock is overvalued or undervalued compared to its peers.
- Examining Avicanna's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Avicanna's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Avicanna's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Avicanna's stock. These opinions can provide insight into Avicanna's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Avicanna Stock
Avicanna financial ratios help investors to determine whether Avicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avicanna with respect to the benefits of owning Avicanna security.